TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

Roche, Alnylam to initiate Phase 3 cardiovascular outcomes trial of zilebesiran

TipRanks 30-Aug-2025 5:07 PM

Roche (RHHBY) and Alnylam (ALNY) announced the decision to initiate a Phase 3 cardiovascular outcomes trial to evaluate the ability of zilebesiran,...
Market Data Delayed 15 Minutes